We are live on
!
Find out more
Allianz Asset Management Portfolio holdings
AUM
$95.4B
1-Year Est. Return
38.74%
This Fund
S&P 500
This Quarter
Est. Return
+1.01%
1 Year Est. Return
+38.74%
3 Year Est. Return
+101.74%
5 Year Est. Return
+133.96%
10 Year Est. Return
+765.1%
AUM
$93.9B
AUM Growth
+$6.32B
(+7.2%)
Cap. Flow
+$695M
Cap. Flow
% of AUM
0.74%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
2,650
New
346
Increased
928
Reduced
896
Closed
297
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$347M |
| 2 |
Cummins
CMI
|
+$334M |
| 3 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$312M |
| 4 |
AbbVie
ABBV
|
+$285M |
| 5 |
Eaton
ETN
|
+$271M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$385M |
| 2 |
DuPont de Nemours
DD
|
+$376M |
| 3 |
GSK
GSK
|
+$357M |
| 4 |
Norfolk Southern
NSC
|
+$288M |
| 5 |
Freeport-McMoran
FCX
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.03% |
| 2 | Technology | 12.99% |
| 3 | Healthcare | 11.81% |
| 4 | Consumer Discretionary | 7.48% |
| 5 | Industrials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
1051
DELISTED
Clovis Oncology, Inc.
CLVS
| $8.72M | 0.01% |
99,215
-99,695
| -50% | -$8.53M |
|
1052
Corpay
CPAY
$25.7B
| $8.66M | 0.01% |
55,516
-1,360
| -2% | -$213K |
|
1053
CALL
Cleveland-Cliffs
CLF
$6.99B
| $8.66M | 0.01% |
2,000,000
-6,002,900
| -75% | -$31.9M |
|
1054
Stantec
STN
$8.39B
| $8.64M | 0.01% |
241,382
-4,562
| -2% | -$125K |
|
1055
PUT
VF Corp
VFC
$5.89B
| $8.6M | 0.01% |
130,945
+9,346
| +8% | +$632K |
|
1056
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.58B
| $8.59M | 0.01% |
85,503
| – | – |
|
1057
AMERISAFE
AMSF
$540M
| $8.56M | 0.01% |
181,998
+20,407
| +13% | +$919K |
|
1058
Service Corp International
SCI
$11.6B
| $8.55M | 0.01% |
289,907
-689,373
| -70% | -$19.6M |
|
1059
PUT
Archer Daniels Midland
ADM
$36.9B
| $8.52M | 0.01% |
176,700
-16,900
| -9% | -$853K |
|
1060
SPS Commerce
SPSC
$2.64B
| $8.49M | 0.01% |
258,196
+45,540
| +21% | +$1.53M |
|
1061
PUT
Devon Energy
DVN
$47.3B
| $8.48M | 0.01% |
142,500
+53,600
| +60% | +$3.46M |
|
1062
PUT
Dollar General
DG
$27.9B
| $8.47M | 0.01% |
+108,900
| New | +$8.22M |
|
1063
Boston Properties
BXP
$11.1B
| $8.45M | 0.01% |
69,798
+4,457
| +7% | +$587K |
|
1064
International Flavors & Fragrances
IFF
$21.9B
| $8.42M | 0.01% |
77,013
+615
| +0.8% | +$71K |
|
1065
Brink's
BCO
$4.62B
| $8.38M | 0.01% |
284,753
-854,579
| -75% | -$25.8M |
|
1066
PUT
Truist Financial
TFC
$64B
| $8.37M | 0.01% |
207,600
+16,700
| +9% | +$661K |
|
|
CSII
1067
DELISTED
Cardiovascular Systems, Inc.
CSII
| $8.32M | 0.01% |
314,675
+32,044
| +11% | +$1.04M |
|
1068
DexCom
DXCM
$32B
| $8.31M | 0.01% |
415,500
-26,320
| -6% | -$462K |
|
1069
Synchrony
SYF
$25.6B
| $8.3M | 0.01% |
251,995
+58,155
| +30% | +$1.86M |
|
|
CYBR
1070
DELISTED
CyberArk
CYBR
| $8.3M | 0.01% |
132,070
+3,795
| +3% | +$243K |
|
1071
PUT
PPG Industries
PPG
$26.6B
| $8.28M | 0.01% |
72,200
-3,600
| -5% | -$411K |
|
|
MBLY
1072
DELISTED
Mobileye N.V.
MBLY
| $8.28M | 0.01% |
155,710
+15,470
| +11% | +$733K |
|
1073
CALL
Bristol-Myers Squibb
BMY
$132B
| $8.25M | 0.01% |
124,000
+67,700
| +120% | +$4.46M |
|
1074
FirstEnergy
FE
$27.5B
| $8.22M | 0.01% |
252,381
+19,696
| +8% | +$689K |
|
1075
Healthpeak Properties
DOC
$14.8B
| $8.21M | 0.01% |
247,042
+18,184
| +8% | +$662K |
|
Similar funds
Allianz Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Allianz Asset Management held 2,650 positions worth $93.9B, up 7.2% from $87.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Allianz Asset Management's Q2 2015 filing shows 346 new, 928 increased, 896 reduced and 297 closed positions. Its largest new stake was UBS Group: 16,594,232 shares worth $348M. The largest sale was Baxter International, an estimated $385M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.
- Allianz Asset Management's largest Q2 2015 buy was UBS Group: 16,594,232 shares worth $348M.
- Allianz Asset Management added most to Cummins in Q2 2015, an estimated $334M increase.
- Allianz Asset Management's biggest Q2 2015 reduction was Baxter International, cutting an estimated $385M.
- Allianz Asset Management fully exited GSK in Q2 2015, selling an estimated $357M.
- Allianz Asset Management's ten largest holdings make up 12% of its $93.9B portfolio in Q2 2015.
- Allianz Asset Management opened 346 new positions and closed 297 in Q2 2015.
- Allianz Asset Management's portfolio value rose 7.2% quarter-over-quarter to $93.9B.
Based on Allianz Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.